Compound Detail
CHEMBL511584
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL511584 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | PCIRKVWUDZUJTF-UHFFFAOYSA-N |
2
Targets
2
Activities
2
Assay Types
0
PK Parameters
6
Publications
0
Known Names
Molecular Properties
309.8
MW (Da)
4.62
ALogP
3
HBA
0
HBD
39.2
PSA (Ų)
0.66
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
EC50 1 meas. best 7.23
IC50 1 meas. best 6.82
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| SARS-CoV-2 CHEMBL4303835 | EC50 | 7.23 | 7.23 | 58.7 | 1 |
| Replicase polyprotein 1ab CHEMBL4523582 | IC50 | 6.82 | 6.82 | 150.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| SARS-CoV-2 | EC50 | = | 58.7 | nM | 7.23 | Antiviral activity against SARS CoV-2 infected in human Calu-3 cells assessed as... | 39146284 |
| Replicase polyprotein 1ab | IC50 | = | 150.0 | nM | 6.82 | Inhibition of full-length SARS CoV-2 MPro expressed in Escherichia coli BL21(DE3... | 39146284 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 18407505 | 10.1016/j.bmc.2008.03.059 | Unchecked | 3 |
| 39146284 | 10.1021/acs.jmedchem.4c00535 | Replicase polyprotein 1ab | 2 |
| 39146284 | 10.1021/acs.jmedchem.4c00535 | ADMET | 2 |
| 39146284 | 10.1021/acs.jmedchem.4c00535 | Calu-3 | 2 |
| 39146284 | 10.1021/acs.jmedchem.4c00535 | Unchecked | 1 |
| 39146284 | 10.1021/acs.jmedchem.4c00535 | SARS-CoV-2 | 1 |
Data from ChEMBL 36 via Core Engine